SOURCE: CompuMed, Inc.

CompuMed, Inc.

September 13, 2012 16:41 ET

CompuMed Signs Contract With Veritas Collaborative to Screen for Cardiac Conditions in Patients With Eating Disorders

LOS ANGELES, CA--(Marketwire - Sep 13, 2012) -   CompuMed, Inc. (PINKSHEETS: CMPD) (www.compumed.net ) -- a leader in telemedicine services for patient diagnosis and management -- has signed a contract with Veritas Collaborative (www.veritascollaborative.com), a specialty behavioral health hospital for young people with eating disorders. CompuMed will provide CardioGram electrocardiogram (ECG) remote over-read services to patients who may have pre-existing cardiac disorders or those who may develop cardiac problems due to anorexia and other related conditions.

Maurizio Vecchione, CompuMed's CEO, made the announcement saying, "We understand the difficulty in treating eating disorders as Veritas patients may also have other underlying conditions such as cardiac problems. It is not uncommon to find bradycardia indicating electrical problems in the heart, as well as ECG findings of low voltage or prolonged QT interval, all relating to a possible eating disorder." He added that in anorexia, cardiac insufficiency is a major concern because as the heart loses contractility and mass, patients can be at risk of heart failure.

Veritas Collaborative Medical Director Dr. Ana Carla Smith will rely on CompuMed to provide ECG testing to those patients with cardiac risk factors and for general screening. "CompuMed is helping us to provide our patients with the highest level of cardiac care using the most accurate cardiac assessment."

The CardioGram system reduces healthcare costs significantly by providing remote cardiac screening at the point-of-care and reducing unnecessary transports to emergency rooms. However, the most unique and life-saving feature of the CardioGram is the device's over-read capabilities or "The Doctor Inside™," which immediately engages one of CompuMed's on-call cardiologists to over-read the computerized interpretation. Cardiologist over-reads can be made available to attending physicians at the point-of-care providing expert interpretations in those situations where the data is ambiguous or difficult to interpret. "The Doctor Inside" is a key element of CompuMed's unique approach to telemedicine and telecardiology.

For more information, contact CompuMed at 310- 258-5000 or sales at (310) 258-5033.

About CompuMed
CompuMed's diagnostic and management tools for the healthcare community focus on telecardiology systems and software solutions. We offer analysis and remote monitoring for patients with cardiovascular and musculoskeletal diseases designed to improve healthcare provider workflow and patient care while reducing costs. CompuMed is headquartered in Los Angeles and distributes its products worldwide both directly and through OEM partners. Visit CompuMed at www.compumed.net and follow on Twitter @compumed.

About Veritas Collaborative
Located in Durham, NC and accredited by The Joint Commission, Veritas Collaborative provides comprehensive, evidence-based care for young males and females with eating disorders & their families -- all within a space intentionally-designed as a locus of engagement & place in which young people can thrive. To learn more about Veritas Collaborative, including the services that they provide and to schedule a visit to Veritas Collaborative's state-of-the-art center, please visit www.veritascollaborative.com or call (919) 908-9730.

Forward Looking Statement
Statements contained in this press release that are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth, results of contracts and other financial results, are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

Contact Information